Abstract |
This article reviews worldwide controversies concerning gestational trophoblastic neoplasms ( hydatidiform mole, invasive mole, and choriocarcinoma). The epidemiology, endocrinology, histopathologic grading, classification, diagnosis, treatment, management and follow-up (including chemotherapy, irradiation, and immunotherapy) of gestational trophoblastic neoplasms - particularly molar pregnancies - are discussed; and ways to help create a standardized classification system and provide optimal treatment for each type of patient are suggested.
|
Authors | D P Goldstein |
Journal | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
(Int J Gynaecol Obstet)
Vol. 15
Issue 3
Pg. 207-15
( 1977)
ISSN: 0020-7292 [Print] United States |
PMID | 205453
(Publication Type: Journal Article)
|
Chemical References |
- Chorionic Gonadotropin
- Dactinomycin
- Methotrexate
|
Topics |
- Chorionic Gonadotropin
(blood)
- Dactinomycin
(therapeutic use)
- Female
- Humans
- Hydatidiform Mole
(drug therapy, therapy)
- Methotrexate
(therapeutic use)
- Pregnancy
- Trophoblastic Neoplasms
(classification, drug therapy, immunology)
- Uterine Neoplasms
(classification, drug therapy, immunology, therapy)
|